CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6968 result(s)

Idursulfase (Elaprase)

Last Updated: July 13, 2007
Result type: Reports
Product Line: Common Drug Review
Generic Name: Idursulfase
Indications: Mucopolysaccharidosis II (MPS II), Hunter Syndrome

  • Brand Name: Elaprase
  • Manufacturer: Shire Human Genetic Therapies, Inc.
  • Project Number: S0104
  • Project Status: Complete
  • Submission Type: New

Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment

Published on: March 27, 2014
Result type: General Content

The Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment recognizes and celebrates individuals whose outstanding achievements have significantly advanced the field of health technology assessment (HTA) in Canada. The award is named in honour of Dr. Jill M. Sanders, President and CEO of CADTH from 1987 to 2010. Dr. Sanders led ...

Previous Recipients

Published on: November 5, 2014
Result type: General Content

2019 2018 2017 Dr. Devidas Menon, Professor and Senior Advisor, Health Technology and Policy Unit, School of Public Health, University of Alberta, Edmonton, Alberta. 2016 Dr. Tom Noseworthy, Professor of Health Policy and Management, Department of Community Health...